We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK’s Daprodustat for CKD-Linked Anemia Shows Promise in Late-Stage Trials
GSK’s Daprodustat for CKD-Linked Anemia Shows Promise in Late-Stage Trials
GlaxoSmithKline released positive topline results from five clinical studies of daprodustat, its investigational drug for treatment of anemia that occurs with chronic kidney disease (CKD).